SCHEMBL3801900

SCHEMBL3801900

[CH2]CNC(=C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16944251 0.74
SCHEMBL12279311 0.71
SCHEMBL17236491 0.71
SCHEMBL809628 0.69
SCHEMBL5380292 0.69
SCHEMBL3048552 0.69
SCHEMBL12207268 0.69
SCHEMBL21064371 0.69
SCHEMBL13775947 0.69
SCHEMBL209839 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1244460-B8 USE OF DIPYRIDINIUM COMPOUNDS FOR TREATING A DISEASE CHARACTERIZED BY PROLIFERATING CELLS CONTAINING NITRIC OXIDE SYNTHASE UNIV DUKE (US) 2010-05-19 EP disclosed
EP-1244460-A4 TREATMENTS BASED ON DISCOVERY THAT NITRIC OXIDE SYNTHASE IS A PARAQUAT DIAPHORASE UNIV DUKE (US) 2004-10-06 EP disclosed
EP-1244460-A1 TREATMENTS BASED ON DISCOVERY THAT NITRIC OXIDE SYNTHASE IS A PARAQUAT DIAPHORASE DUKE UNIVERSITY (US) 2002-10-02 EP disclosed
WO-2001028568-A1 TREATMENTS BASED ON DISCOVERY THAT NITRIC OXIDE SYNTHASE IS A PARAQUAT DIAPHORASE DUKE UNIVERSITY (US) 2001-04-26 WO disclosed